Medical/Pharmaceuticals

First-ever successful mind-controlled robotic arm without brain implants

PITTSBURGH, June 20, 2019 /PRNewswire/ -- A team of researchers from Carnegie Mellon University, in collaboration with the University of Minnesota, has made a breakthrough in the field of noninvasive robotic device control. Using a noninvasive brain-computer interface (BCI), researchers have deve...

2019-06-20 02:05 1953

dMed Biopharmaceutical, a next generation CRO, announced the opening of its US Regulatory Affairs office in Washington DC to build a bridge for affordable innovative drugs for US patients

WASHINGTON, June 19, 2019 /PRNewswire/ -- Since the China launch earlier this year of an immuno-oncology drug at one-third the price of Merck's Keytruda, there has been a wave of applications for affordable innovative therapies from China, developed to Western standards of safety and efficacy, ...

2019-06-19 23:59 1588

CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the U.S. FDA

SHANGHAI, June 19, 2019 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced that one of its leading drug candidates, CT053 fully human BCMA (B-Cell Maturation Antigen)-CAR-T cell for the trea...

2019-06-19 18:00 2220

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019

Added 22,194 New Subscribers in 4Q19 4Q19 Revenues Increased by 8.0% YoY to RMB251.7 Million ($37.5 Million) 4Q19 Operating Income Increased to RMB88.9 Million ($13.2 Million) Conference Call to be Held on June 19, 2019 at 8:00 a.m. ET HONG KONG, June 19, 2019 /PRNewswire/ -- Global Cord Blood Corp...

2019-06-19 04:16 10705

Piramal Pharma Solutions recognized by Frost & Sullivan for its End-to-End Integrated Services Across the Entire Drug Development Life Cycle

SANTA CLARA, California, June 18, 2019 /PRNewswire/ -- Based on its recent analysis of the contract development and manufacturing organization market, Frost & Sullivan recognized Piramal Pharma Solutions ('PPS', 'the business') with the 2019 Global Customer Service Leadership Award. Through its 1...

2019-06-18 20:00 1147

Seegene Establishes Brazilian Subsidiary

SEOUL, South Korea, June 18, 2019 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced today the formation of a new subsidiary, Seegene do Brasil Diagnosticos Ltda., inBelo Horizonte, Brazil. Seegene do Brasil Diagnos...

2019-06-18 19:00 892

Golden State Killer Case Selected As 2019 DNA Hit Of The Year

The forty-five-year investigation resulted in arrest after law enforcement's use of investigative genetic genealogy KOBE, Japan, June 18, 2019 /PRNewswire/ -- Gordon Thomas Honeywell Governmental Affairs (GTH-GA) has announced that the Golden State Killer case was selected as the 2019 DNA Hit of...

2019-06-18 11:30 1409

Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings

SUZHOU, China, June 18, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the clinical results of CT103A, the potential best-in-class therapy of fully-human ...

2019-06-18 08:00 4502

AXA Hong Kong, CUHK and Oxford VR join forces to revolutionise mental health care by launching Asia-first VR therapy solution

HONG KONG, June 17, 2019 /PRNewswire/ -- AXA Hong Kong, The Chinese University of Hong Kong (CUHK) and Oxford VR (OVR) have today jointly launched a first-of-its-kind advanced psychological therapy using virtual reality (VR) technology to support better mental health outcomes inAsia including the...

2019-06-17 19:45 1632

Cedrus' Head of Life Sciences Invited to Moderate a Panel at China Focus@BIO and was a Panelist at the Redefining Early Stage Investments Conference in Philadelphia

HONG KONG, June 17, 2019 /PRNewswire/ -- Ms. Kimberly Nearing, Head of Life Sciences atCedrus Investments ("Cedrus") , was invited to moderate the first panel of the China Focus@BIO Conference in Philadelphia held on 2nd June 2019. Kim was also a panelist at the ...

2019-06-17 09:00 1210

Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302 JAK Inhibitor for Ulcerative Colitis and Crohn's Disease

SHANGHAI, June 14, 2019 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone) announced today dosing of the first patient in their Phase II global clinical trials (RSJ10101 and RSJ10201) of SHR0302 in patients with Ulcerative Colitis and Crohn's disease respectively. The Phase II studies ...

2019-06-14 20:30 1364

First Uzbekistani Company in Hong Kong to bring Chinese Medicine Business along "The Belt and Road"

HONG KONG, June 14, 2019 /PRNewswire/ -- On June 13, "The Belt and Road" International Cocktail Reception of Chinese Medicine Innovation and Cooperation was held inHong Kong by Yilin Bagu Group JV LLC. The event was attended by the delegation of H.E.Bakhtiyor Saidov, Ambassador of Uzbekistan i...

2019-06-14 12:48 4236

China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Lefamulin

-  Chinese registrational clinical trial for lefamulin to begin in 2H 2019 BEIJING and SHANGHAI, June 14, 2019 /PRNewswire/ -- Sinovant Sciences today announced that its Clinical Trial Application (CTA) for lefamulin has been accepted by the Center for Drug Evaluation at the China National Medica...

2019-06-14 09:00 3645

New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting

Data Presentation & Lunch Symposium at TVT2019 Structural Heart Summit CHICAGO, June 13, 2019 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, presented data at the TVT2019 S...

2019-06-13 21:10 3358

Lumosa to Initiate Phase 2 Human Clinical Trial in the US and Taiwan for Its LT3001, A Novel Drug for the Treatment of Acute Ischemic Stroke

TAIPEI, Taiwan, June 13, 2019 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; code: 6535.TWO) announced that the company is ready to commence the Phase 2 proof of concept (PoC) study for its LT3001, a novel drug for the treatment of acute ischemic stroke (AIS) that showed good safety, tolerability...

2019-06-13 20:00 2779

Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference

Avalon GloboCare to Unveil the Launch of its Exosome Product Commercialization Plan at the Second Aesthetic Industry Conference, the Largest Aesthetics Conference Across Asia Yu Zhou, M.D., Ph.D., Co-CEO of Avalon's subsidiary GenExosome Technologies to provide keynote address FREEHOLD, New Jer...

2019-06-13 20:00 8024

Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer

* The partnership will leverage Tessa Therapeutics' global operational capabilities and cell therapy platform technologies to target prevalent cancers inChina * The joint venture will be the sole licensee of Tessa Therapeutics' cell therapies for research, development and commercialization in...

2019-06-13 07:15 1440

ISTH President Claire McLintock Receives Officer of the New Zealand Order of Merit on Queen's Birthday Honours List

Award Underscores McLintock's Service to the Fields of Haematology & Obstetrics CHAPEL HILL, North Carolina, June 13, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) today announced that ISTH President Claire McLintock, MD, has received the award of Officer of t...

2019-06-13 02:00 1539

CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA

KFAR SABA, Israel, June 12, 2019 /PRNewswire/ -- CartiHeal, developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, successfully enrolled the 200th patient in the Agili-C™ IDE pivotal clinical study. Surgery was performed byScott ...

2019-06-12 20:38 1431

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial

SAN FRANCISCO, June 12, 2019 /PRNewswire/ -- Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The p...

2019-06-12 02:45 1813
12345678 ... 333

Week's Top Stories